{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:08:15Z","timestamp":1792382895014,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T00:00:00Z","timestamp":1468972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical & Translational Endocrinology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jcte.2016.07.002","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T09:25:12Z","timestamp":1469525112000},"page":"32-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Management of adynamic bone disease in chronic kidney disease: A brief review"],"prefix":"10.1016","volume":"5","author":[{"given":"Swathi K.","family":"Sista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth M.","family":"Arum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2016.07.002_bib0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00198-013-2435-1","article-title":"Incidence and risk factors for hip fractures in dialysis patients","volume":"1","author":"Maravic","year":"2014","journal-title":"Osteoporos Int"},{"issue":"Suppl. 113","key":"10.1016\/j.jcte.2016.07.002_bib0015","first-page":"90","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Chapter 4.3","volume":"76","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcte.2016.07.002_bib0020","first-page":"135","article-title":"Adynamic bone disease \u2013 bone and beyond","volume":"3","author":"Brandenburg","year":"2008","journal-title":"NDT Plus"},{"issue":"3","key":"10.1016\/j.jcte.2016.07.002_bib0025","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1525-139x.2000.00042.x","article-title":"The role of the bone biopsy in the diagnosis of renal osteodystrophy","volume":"13","author":"Sprague","year":"2000","journal-title":"Semin Dial"},{"issue":"121","key":"10.1016\/j.jcte.2016.07.002_bib0030","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/ki.2011.26","article-title":"Phosphate and klotho","volume":"79","author":"Kuro-o","year":"2011","journal-title":"Kidney Int"},{"issue":"121","key":"10.1016\/j.jcte.2016.07.002_bib0035","first-page":"524","article-title":"Phosphate and FGF-23","volume":"79","author":"Juppner","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcte.2016.07.002_bib0040","series-title":"Endotext online endocrinology book","article-title":"Hyperparathyroidism in chronic kidney disease","author":"Drueke","year":"2015"},{"issue":"6","key":"10.1016\/j.jcte.2016.07.002_bib0045","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.semnephrol.2014.09.008","article-title":"Adynamic bone disease: from bone to vessels in chronic kidney disease","volume":"34","author":"Bover","year":"2014","journal-title":"Semin Nephrol"},{"issue":"4","key":"10.1016\/j.jcte.2016.07.002_bib0050","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorous and calcium\u2009\u00d7\u2009phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcte.2016.07.002_bib0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0272-6386(99)70302-1","article-title":"Risk factors for vertebral fractures in renal osteodystrophy","volume":"33","author":"Atsumi","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcte.2016.07.002_bib0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.beem.2013.02.008","article-title":"Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders","volume":"27","author":"Nemeth","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jcte.2016.07.002_bib0065","first-page":"369","article-title":"Adynamic bone decreases bone toughness during aging by affecting mineral and matrix","volume":"31","author":"Ng","year":"2016","journal-title":"J Back Musculoskelet Rehabil"},{"issue":"5","key":"10.1016\/j.jcte.2016.07.002_bib0070","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/j.ajkd.2005.08.013","article-title":"The Kidney Disease Outcomes Quality Initiative (K\/DOQI) guideline for bone metabolism and disease in CKD: association with mortality in dialysis patients","volume":"46","author":"Noordzij","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcte.2016.07.002_bib0075","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/ajkd.2000.19093","article-title":"Parathormone secretion in peritoneal dialysis patients with adynamic bone disease","volume":"36","author":"S\u00e1nchez","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcte.2016.07.002_bib0080","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Ure\u00f1a","year":"1996","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.jcte.2016.07.002_bib0085","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/ndt\/13.9.2294","article-title":"Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients","volume":"13","author":"Coen","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.jcte.2016.07.002_bib0090","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","article-title":"Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy","volume":"46","author":"Goodman","year":"1994","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.jcte.2016.07.002_bib0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2006101089","article-title":"Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients","volume":"19","author":"Ferreira","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jcte.2016.07.002_bib0100","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.ki.5001666","article-title":"Reversal of adynamic bone disease by lowering of dialysate calcium","volume":"70","author":"Haris","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcte.2016.07.002_bib0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000316708","article-title":"Treatment of hemodialysis-associated adynamic bone disease with teriparatide (PTH1-34): a pilot study","volume":"33","author":"Cejka","year":"2010","journal-title":"Kidney Blood Press Res"},{"issue":"6","key":"10.1016\/j.jcte.2016.07.002_bib0110","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/j.ajkd.2015.01.025","article-title":"Teriparatide and bone turnover and formation in a hemodialysis patient with low-turnover bone disease: a case report","volume":"65","author":"Palcu","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcte.2016.07.002_bib0115","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000341864","article-title":"Impact of long-term cinacalcet, ibandronate or teriparatide therapy on bone mineral density of hemodialysis patients: a pilot study","volume":"36","author":"Mitsopoulos","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jcte.2016.07.002_bib0120","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/ckj\/sfv005","article-title":"Treatment of adynamic bone disease in hemodialysis patient with teriparatide","volume":"8","author":"Giamalis","year":"2015","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jcte.2016.07.002_bib0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.coph.2016.02.012","article-title":"New horizons in osteoporosis therapies","volume":"28","author":"Harslof","year":"2016","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"10.1016\/j.jcte.2016.07.002_bib0130","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/jc.2014-3718","article-title":"Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis","volume":"100","author":"Leder","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jcte.2016.07.002_bib0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1759720X15623489","article-title":"Osteoporosis therapeutics: recent developments at ASBMR","volume":"8","author":"Mallarkey","year":"2016","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.jcte.2016.07.002_bib0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McLung","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcte.2016.07.002_bib0145","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jbmr.554","article-title":"Ronacaleret, a calcium-sensing receptor antagonist increases trabecular but not cortical bone in postmenopausal women","volume":"27","author":"Fitzpatrick","year":"2012","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Clinical & Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623716300199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623716300199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:54:33Z","timestamp":1762005273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623716300199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":28,"alternative-id":["S2214623716300199"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2016.07.002","relation":{},"ISSN":["2214-6237"],"issn-type":[{"value":"2214-6237","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of adynamic bone disease in chronic kidney disease: A brief review","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2016.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}